MYCO Profile
- Sector: Health Technology
- Industry: Pharmaceuticals
Mydecine Innovations Group, Inc. is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. The company encompasses three companies: Mindleap Health, Mydecine Health Sciences, and NeuroPharm Inc. The Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind. The Mydecine Health Sciences is a vertically integrated company developing novel fungtional mushroom products and psychedelic medicines for healthy and vulnerable populations. The NeuroPharm is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations. The company was founded by Parente Carman on September 27, 2013 and is headquartered in Vancouver, Canada.
Recent News
Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
Numinus progresses on its ecosystem approach to the ultimate delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a …
Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
— Mydecine Innovations Group Inc. (MYCO.CN) (MYCOF) (0NF.F) (“Mydecine” or the “Company”), is pleased to announce that its subsidiary Mindleap Health’s (“Mindleap” ) telehealth platform …
Nutritional High Provides a Corporate Update
– Nutritional High International Inc. (CSE: EAT) (OTC Pink: SPLIF) (“Nutritional High” or the “Company“)is pleased to provide the following update. Over the past 6 months …
MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor
– Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading drug development company for psychedelic inspired medicines, is evaluating an expanded United States investor base through …
PSYC Revamps Their Online Presence with a Relaunch of Corporate Website
— Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company has completed the redevelopment and relaunch …
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics …
Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets
— Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), today announced the Company has formed a special committee to evaluate a number …
Red White & Bloom Closes Platinum Vape Acquisition Ahead of Previous Timeline Guidance
– Platinum’s products are sold within Michigan, California and, Oklahoma in over 700 retailers -PV has current annualized revenues of more than USD $75 million …
Numinus Announces Closing of Oversubscribed $4.6 Million Offering
– Numinus Wellness Inc. (“Numinus” or the “Company“) (TSXV: NUMI), is pleased to announce that it has closed its previously announced short form prospectus offering, on …
Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics …
- Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders
- Meta Growth Announces Filing of Management Information Circular in Connection with Proposed Arrangement with High Tide
- MediPharm Labs Expands Denmark Revenue Opportunity, Enters New Supply Agreement with DanCann Pharma
- Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020
- Red White & Bloom Brands Inc. Announces Closing of $25 Million Bought Deal Offering of Units, Including Full Exercise of the Over-Allotment Option
- Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
- Zenabis Announces Closing of Public Offering of Units
- Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
- VIVO Cannabis™ Completes Debenture Refinancing
- Meta Growth Announces Opening of New Cannabis Retail Store in Winnipeg
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.